Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,087 across all filing types
Latest filing 2023-04-21 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - HORIZON THERAPEUTICS PLC
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Horizon Therapeutics PLC). This type of filing is a standard regulatory requirement for major shareholders during M&A activity to ensure transparency. While it relates to M&A, it is specifically a 'Major Shareholding Notification' regarding the disclosure of positions and dealings, which fits the 'MRQ' category.
2023-04-21 English
Form 8.3 - HORIZON THERAPEUTICS PLC
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Horizon Therapeutics PLC). This type of filing is a standard regulatory requirement for major shareholders during M&A activity and is classified as a Major Shareholding Notification (MRQ) as it pertains to the disclosure of significant ownership levels and dealings related to a takeover.
2023-04-20 English
Form 8.3 - HORIZON THERAPEUTICS PLC
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the interests, short positions, and dealings in the securities of an offeror/offeree (Horizon Therapeutics PLC) by a major shareholder (Citadel Group). This type of disclosure is specifically related to M&A activity and takeover rules, but since it is a mandatory regulatory disclosure of shareholding positions and dealings, it falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership and changes in positions during a takeover process.
2023-04-19 English
Form 8.3 - HORIZON THERAPEUTICS PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in relation to an offeror or offeree during a takeover period. This falls under the category of 'Major Shareholding Notification' (MRQ) as it reports significant share ownership and changes in holdings related to a takeover event.
2023-04-18 English
Form 8.3 - HORIZON THERAPEUTICS PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the opening position and dealings in the securities of Horizon Therapeutics PLC by Citadel Group. This type of document is a mandatory regulatory disclosure regarding major shareholding interests and dealings during a takeover period, which falls under the 'Major Shareholding Notification' category.
2023-04-17 English
Form 8.3 - Horizon Therapeutics plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the opening position and dealings of Citadel Group in the securities of Horizon Therapeutics PLC. This type of document is a mandatory regulatory disclosure regarding shareholdings and dealings during a takeover period, which falls under the 'Regulatory Filings' (RNS) category as it is a specific regulatory announcement distributed via a Regulatory Information Service.
2023-04-14 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.